Fundraising FoxMichal Silverberg
InvestorManaging Director at Novartis Venture Fund
Boston, Massachusetts
Writes $5M – $10M checks · typically $7.5M
Find your path to Michal
Sign up to see every warm intro you have to Michal
- Paths you didn't know you had: your email and LinkedIn already hold routes to Michal. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Contact· self-published, not guessed
Deals · 1
ImmPACT Bio USA Inc.Board seat
via Novartis Venture Fund · filed Aug 2020 · $5.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Fore BiotherapeuticsSidewinder TherapeuticsTwentyeight-Seven Therapeutics
Sources: SEC Form D filings · curated public sources.
Colleagues at Novartis Venture Fund
Frequently asked questions
- Who is Michal Silverberg?
- Managing Director at Novartis Venture Fund
- Where does Michal Silverberg work?
- Michal Silverberg is Managing Director at Novartis Venture Fund.
- What check size does Michal Silverberg write?
- Michal Silverberg typically writes checks of $5M – $10M.
- What boards does Michal Silverberg sit on?
- Michal Silverberg holds tracked board seats at ImmPACT Bio USA Inc..
- What companies has Michal Silverberg invested in?
- Investments tracked here include Fore Biotherapeutics, Sidewinder Therapeutics, Twentyeight-Seven Therapeutics.
About this profile. Compiled from public sources — Novartis Venture Fund's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights